Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ERSIAS IIb. EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-Occlusive Disease. Phase IIb Clinical Trial

NCT07864649 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT07864649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07864649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ERSIAS IIb. EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-Occlusive Disease. Phase IIb Clinical Trial
Lead sponsor
Cedars-Sinai Medical Center
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2027
Completion date
November 30, 2031
Enrollment
170 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial arterial stenosis, intracranial atherosclerosis, ischemic stroke